Gainers
- Stoke Therapeutics (NASDAQ:STOK) shares increased by 46.1% to $15.03 during Wednesday's regular session. The company's market cap stands at $671.1 million. As per the press release, Q4 earnings came out 2 days ago.
- Lixte Biotechnology (NASDAQ:LIXT) shares rose 43.68% to $3.24. The company's market cap stands at $7.2 million.
- Nuvation Bio (NYSE:NUVB) shares moved upwards by 35.41% to $3.9. The company's market cap stands at $854.2 million.
- Ontrak (NASDAQ:OTRK) shares moved upwards by 29.18% to $0.55. The market value of their outstanding shares is at $15.2 million.
- PAVmed (NASDAQ:PAVM) stock increased by 25.72% to $2.59. The market value of their outstanding shares is at $20.8 million. The company's, Q4 earnings came out yesterday.
- Nutriband (NASDAQ:NTRB) stock rose 24.33% to $3.78. The market value of their outstanding shares is at $31.9 million.
Losers
- Akili (NASDAQ:AKLI) stock declined by 18.8% to $0.31 during Wednesday's regular session. The company's market cap stands at $24.3 million.
- Mesoblast (NASDAQ:MESO) shares declined by 12.85% to $3.42. The company's market cap stands at $347.5 million.
- Salarius Pharmaceuticals (NASDAQ:SLRX) stock fell 11.19% to $0.44. The company's market cap stands at $1.7 million. As per the news, the Q4 earnings report came out 3 days ago.
- XTL Biopharmaceuticals (NASDAQ:XTLB) shares fell 11.08% to $2.73. The market value of their outstanding shares is at $14.8 million.
- Fresh2 Group (NASDAQ:FRES) shares declined by 10.6% to $0.57. The market value of their outstanding shares is at $13.5 million.
- PDS Biotechnology (NASDAQ:PDSB) shares decreased by 9.94% to $4.04. The company's market cap stands at $125.5 million. As per the press release, Q4 earnings came out today.
This article was generated by Benzinga's automated content engine and reviewed by an editor.